Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TransMedics Inc.

www.transmedics.com

Latest From TransMedics Inc.

Panel Recommends Approval Of Lung Transplant Device, Despite FDA Concerns

TransMedics Organ Care System helps to preserve lungs for transplant, and was recommended for approval despite significant US FDA concerns over trial conduct.

Advisory Committees Surgery

AdComms To Meet On TransMedics Organ Transplant Device, Discuss '21st Century' Funds

Two US FDA advisory committee meetings are scheduled for May. One will delve into a new organ-transplant device intended to keep organs viable longer, while the other will present recommendations on how the agency should spend funds from the 21st Century Cures Act.

FDA Advisory Committees

Device/Diagnostics Quarterly Deal Statistics, Q2 2016

Medtech companies brought in $1.5 billion in Q2 2016, 15% less than Q1, with debt offerings accounting for more than half the total; acquisitions more than doubled due to Abbott's $25 billion takeover of St. Jude Medical. Diagnostics financings were down 34% from Q1 and acquisition volume, also lower, was mainly Thermo Fisher Scientific's $4.2 billion buy of FEI.

Deals Market Intelligence

Venture Funding Deals, July 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Immune Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • TransMedics Inc.
  • Senior Management
  • Waleed Hassanein, MD, Pres. & CEO
    Stephen Gordon, CFO
    Tamer Khayal, MD, CMO
    Neal Beswick, VP, Bus. Dev.
    Marienne Sanders, VP, Global Mktg.
  • Contact Info
  • TransMedics Inc.
    Phone: (978) 552-0900
    200 Minuteman Rd.
    Ste. 302
    Andover, MA 01810
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register